Chargement en cours...
CD122 signaling in CD8(+) memory T cells drives costimulation-independent rejection
Interrupting T cell costimulatory signals as a strategy to control undesired immune responses, such as occur in autoimmunity or transplantation, has the potential to alleviate many of the unwanted side effects associated with current immunosuppressive therapies. Belatacept, a high-affinity version o...
Enregistré dans:
| Publié dans: | J Clin Invest |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Clinical Investigation
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159972/ https://ncbi.nlm.nih.gov/pubmed/30222140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI95914 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|